Emergent BioSolutions | Creditori Commerciali





Creditori Commerciali Cambiamento Data
Acadia Pharmaceuticals USD 21.75M 1.65M 2025-09
Akebia Therapeutics USD 10.09M 1.47M 2025-09
ALKERMES USD 68M 31.21M 2025-09
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
Amarin USD 36.71M 8M 2025-09
ANI Pharmaceuticals USD 69.8M 15.23M 2025-09
BioMarin Pharmaceutical USD 798.44M 114.19M 2025-09
Coherus Biosciences USD 24.89M 12.73M 2025-09
Emergent BioSolutions USD 112.2M 500K 2023-12
Exact Sciences USD 175.87M 46.51M 2025-12
Exelixis USD 29.62M 4.27M 2025-12
Glaxosmithkline GBP 21.07B 7.42B 2025-09
Heron Therapeutics USD 12.02M 20K 2025-09
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
Ironwood Pharmaceuticals USD 1.61M 224K 2025-09
Lexicon Pharmaceuticals USD 5.9M 4.79M 2025-06
Lonza CHF 471M 3M 2024-12
Merck USD 4.15B 102M 2025-09
Moderna USD 317M 50M 2025-12
Myriad Genetics USD 31.8M 900K 2025-09
Nektar Therapeutics USD 15.56M 1.28M 2025-09
Neurocrine Biosciences USD 545.5M 425.6M 2025-12
Pacira USD 17.69M 12.44M 2025-09
Pfizer USD 5.02B 142M 2025-09
PTC Therapeutics USD 36.62M 169.69M 2025-09
Sanofi EUR 22.93B 927M 2025-12
Sarepta Therapeutics USD 94.02M 42.69M 2025-09
United Therapeutics USD 468M 36M 2025-09
Vanda Pharmaceuticals USD 39.09M 33.28M 2024-12
Xoma USD 2.65M 1.52M 2025-09


Emergent BioSolutions Creditori Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.